|[August 26, 2014]
Research and Markets: Medical Imaging Reagents Market Report - Class, Technology & Application Analysis 2014-2019
DUBLIN --(Business Wire)--
Research and Markets (http://www.researchandmarkets.com/research/lf2fd6/medical_imaging)
has announced the addition of the "Medical
Imaging Reagents Market - Global Industry Analysis, Size, Share, Growth,
Trends and Forecast, 2013 - 2019" report to their offering.
The medical imaging reagents market is categorized on the basis of
class, technology and applications. The three main classes of imaging
reagents are contrast reagents, optical reagents and nuclear reagents.
The contrast reagents market of the medical imaging reagents accounted
for the largest market in 2011 (44%). However, the nuclear reagents
market is expected to experience the fastest growth rate during the
forecast period owing to the high adoption rate for localized tracers
and nuclear medicine. Moreover, the technology segment comprises
nanoparticles, fluorescent proteins, radiopharmaceuticals, quantum dots,
fluorescent dyes and probes.
Among these, nanoparticles technology is expected to grow at a high
growth rate of over 8% from 2013 t 2019 due to the widespread
applicability of these technologies along with high research and
development initiatives being taken up for the development of their
application areas. Furthermore, in terms of applications, this market is
categorized into diagnostics, drug discovery and development as well as
research and development; among which, drug discovery and development is
expected to witness the highest growth during the forecast period.
This growth can be attributed to the growing adoption rate of medical
imaging reagents in the pre-clinical studies and medical interventions.
However, diagnostic applications accounted for the largest market in
terms of revenue due to the escalating patient base of chronic diseases
(e.g. cancer, cardiovascular and neurological diseases).
North America is the largest market for medical imaging reagents owing
to the increased incidence of cancer, cardiovascular and neurological
diseases as well as high awareness about advanced imaging modalities and
reagents, followed by Europe. However, rise in healthcare expenditure
and the prevailing unstable economic conditions have led to a sluggish
growth in the global medical imaging reagents market. Asia-Pacific is
expected to foresee the highest growth due to strong economic
developments, high incidence rate of cardiovascular diseases coupled
with increasing demand for non-ionizing imaging reagents.
Class: Contrast Reagents, Optical Reagents and Nuclear Reagents
Technology: Nanoparticles, Fluorescent Proteins, Fluorescent Dyes and
Probes, Radiopharmaceuticals and Quantum (News - Alert) Dots &
Application: Diagnostics, Drug Discovery and Development and Research
Bayer Healthcare AG
Beckman Coulter, Inc.
Becton Dickinson & Company
Bracco Imaging SpA
Cardinal Health, Inc.
Lantheus Medical Imaging, Inc.
Siemens (News - Alert) Healthcare
Thermo Fisher Scientific, Inc.
For more information visit http://www.researchandmarkets.com/research/lf2fd6/medical_imaging
[ Back To TMCnet.com's Homepage ]